Quick Takeaways
- HTFL - Heartflow, Inc. has 13 insiders with reported activity on this page.
- Net insider value flow over the last year: -$62,092,963.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 13 Insiders of Heartflow, Inc.
- Symbol
- HTFL on Nasdaq
- Location
- San Francisco, CA
What Changed
- Buy value: $1,053,680; sell value: $63,146,643.
- Net share flow: -2,239,027.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$62,092,963.
Buys
$1,053,680
Shares: 40,000
Insiders: 1
Sells
$63,146,643
Shares: 2,279,027
Insiders: 4
Net
-$62,092,963
Shares: -2,239,027
Insiders: -3
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 2,279,027 | $0 | $63,146,643 | -$63,146,643 |
| 3-6 | 40,000 | 0 | $1,053,680 | $0 | +$1,053,680 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Heartflow, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10%+ Owner | $293,070,831 | -$56,100,000 | -16% | Filing P/S | 04 Feb 2026 |
| Jeffrey C. Lightcap | Director | $217,828,174 | +$1,053,680 | +0.49% | Mixed | 24 Mar 2026 |
| John C.m. Farquhar | Chief Executive Officer, Director | $14,673,635 | -$1,756,421 | -11% | Filing P/S | 10 Apr 2026 |
| Vikram Verghese | Chief Financial Officer | $6,826,516 | Mixed | 06 Feb 2026 | ||
| Campbell Rogers | Chief Medical Officer | $6,238,378 | -$4,843,613 | -44% | Mixed | 01 Apr 2026 |
| Timothy C. Barabe | Director | $4,037,427 | Mixed | 11 Mar 2026 | ||
| Marie L. Jones | Chief Accounting Officer, VP | $1,015,015 | Mixed | 06 Feb 2026 | ||
| Julie A. Cullivan | Director | $682,275 | -$446,610 | -40% | Filing P/S | 05 Mar 2026 |
| HealthCor Partners Management LP | 10%+ Owner | $0 | Mixed | 11 Aug 2025 | ||
| William C. Weldon | Director | Mixed | 07 Aug 2025 | |||
| Casey M. Tansey | Director | Mixed | 07 Aug 2025 | |||
| Wayne J. Riley | Director | Mixed | 07 Aug 2025 | |||
| Nicholas Downing | Director | Mixed | 07 Aug 2025 |
Top shareholders of Heartflow, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BCLS Fund III Investments, LP |
13D/G
|
— |
15%
|
12,448,158
|
$419,004,998 | $0 | 30 Sep 2025 | |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
12%
from 3/4/5
|
12,448,158
|
$362,863,806 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
14%
|
11,921,247
|
$268,108,845 | +$135,551,211 | 27 Feb 2026 | |
| Jeffrey C. Lightcap |
3/4/5
|
Director |
—
mixed-class rows
|
6,991,237
mixed-class rows
|
$217,828,174 | +$1,053,680 | 24 Mar 2026 | |
| Hayfin Special Opportunities Fund II LP |
13D/G
|
Hayfin Management Holdings Limited |
6.2%
|
5,283,264
|
$177,834,666 | $0 | 30 Sep 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
5.7%
|
4,730,234
|
$159,219,679 | $0 | 30 Sep 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
3.5%
|
3,005,998
|
$87,624,842 | — | 31 Dec 2025 | |
| BAMCO INC /NY/ |
13F
|
Company |
2.7%
|
2,303,877
|
$67,158,015 | — | 31 Dec 2025 | |
| Schusterman Interests, LLC |
13F
|
Company |
2.2%
|
1,939,201
|
$56,527,709 | — | 31 Dec 2025 | |
| HealthCor Partners Management LP |
13D/G
3/4/5
|
10%+ Owner |
2.4%
|
2,082,014
|
$48,261,085 | -$106,988,264 | 24 Mar 2026 | |
| Capricorn Investment Group LLC |
13F
|
Company |
1.9%
|
1,661,601
|
$48,177,645 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
1,580,313
|
$46,066,124 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.6%
|
1,431,011
|
$41,713,971 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.5%
|
1,342,139
|
$39,123,352 | — | 31 Dec 2025 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,259,121
|
$36,703,377 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
1,248,898
|
$36,405,377 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.3%
|
1,089,030
|
$31,745,225 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1%
|
865,560
|
$25,231,275 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
863,271
|
$25,165,000 | — | 31 Dec 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.91%
|
790,903
|
$23,055,000 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.86%
|
745,924
|
$21,743,717 | — | 31 Dec 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.81%
|
700,805
|
$20,428,466 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.79%
|
685,159
|
$19,972,385 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.68%
|
586,282
|
$17,090,121 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.67%
|
577,397
|
$16,831,122 | — | 31 Dec 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.58%
|
505,989
|
$14,749,579 | — | 31 Dec 2025 | |
| John C.m. Farquhar |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
870,422
mixed-class rows
|
$14,673,635 | -$1,756,421 | 10 Apr 2026 | |
| UBS Group AG |
13F
|
Company |
0.58%
|
501,165
|
$14,608,961 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.58%
|
499,925
|
$14,575,256 | — | 31 Dec 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.57%
|
495,000
|
$14,429,250 | — | 31 Dec 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
440,508
|
$12,840,808 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.37%
|
322,351
|
$9,396,532 | — | 31 Dec 2025 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.36%
|
312,234
|
$9,101,621 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.35%
|
304,487
|
$8,875,796 | — | 31 Dec 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.32%
|
277,700
|
$8,094,955 | — | 31 Dec 2025 | |
| Vikram Verghese |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
332,548
mixed-class rows
|
$6,826,516 | — | 06 Feb 2026 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.26%
|
228,617
|
$6,664,186 | — | 31 Dec 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.26%
|
225,000
|
$6,558,750 | — | 31 Dec 2025 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.26%
|
221,582
|
$6,459,115 | — | 31 Dec 2025 | |
| Campbell Rogers |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
308,175
mixed-class rows
|
$6,238,378 | -$4,843,613 | 01 Apr 2026 | |
| NZS Capital, LLC |
13F
|
Company |
0.24%
|
209,688
|
$6,112,405 | — | 31 Dec 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.21%
|
185,868
|
$5,418,052 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
153,346
|
$4,470,036 | — | 31 Dec 2025 | |
| Freestone Grove Partners LP |
13F
|
Company |
0.17%
|
150,000
|
$4,372,500 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.17%
|
147,195
|
$4,290,734 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
138,762
|
$4,044,912 | — | 31 Dec 2025 | |
| Timothy C. Barabe |
3/4/5
|
Director |
—
mixed-class rows
|
194,933
mixed-class rows
|
$4,037,427 | — | 11 Mar 2026 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.15%
|
131,262
|
$3,826,287 | — | 31 Dec 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.13%
|
113,857
|
$3,318,932 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.13%
|
110,509
|
$3,222,000 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Heartflow, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| John C.m. Farquhar | HTFL | Common Stock | Sale | -3.95% | $602,857 | $26.72 | -22,562 | 549,163 | 10 Apr 2026 | Direct |
| Campbell Rogers | HTFL | Common Stock | Sale | -44.3% | $1,590,093 | $24.64 | -64,533 | 81,002 | 01 Apr 2026 | Direct |
| Campbell Rogers | HTFL | Common Stock | Options Exercise | 85.4% | 67,017 | 145,535 | 01 Apr 2026 | Direct | ||
| Campbell Rogers | HTFL | Stock Option | Options Exercise | -94.8% | -60,168 | 3,298 | 01 Apr 2026 | Direct | ||
| Campbell Rogers | HTFL | Stock Options | Options Exercise | -100% | -6,849 | 0 | 01 Apr 2026 | Direct | ||
| Jeffrey C. Lightcap | HTFL | Common Stock | Other | 515.6% | 206,261 | 246,261 | 24 Mar 2026 | Direct | ||
| HealthCor Partners Management LP | HTFL | COMMON STOCK | Other | -100% | -4,615,542 | 0 | 24 Mar 2026 | By HCPCIV I, LLC | ||
| Campbell Rogers | HTFL | Common Stock | Sale | -45.1% | $1,658,033 | $25.69 | -64,533 | 78,518 | 19 Mar 2026 | Direct |
| Campbell Rogers | HTFL | Common Stock | Options Exercise | 88.1% | 67,017 | 143,051 | 19 Mar 2026 | Direct | ||
| Campbell Rogers | HTFL | Stock Option | Options Exercise | -32.1% | -67,017 | 141,510 | 19 Mar 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Sale | -1.67% | $243,125 | $25.00 | -9,725 | 571,725 | 18 Mar 2026 | Direct |
| Timothy C. Barabe | HTFL | Common Stock | Options Exercise | 5.07% | 8,667 | 179,521 | 11 Mar 2026 | Direct | ||
| Timothy C. Barabe | HTFL | Stock Option | Options Exercise | -36% | -8,667 | 15,412 | 11 Mar 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Sale | -2.16% | $290,886 | $22.66 | -12,837 | 581,450 | 10 Mar 2026 | Direct |
| John C.m. Farquhar | HTFL | Common Stock | Award | 0.44% | 2,631 | 594,287 | 06 Mar 2026 | Direct | ||
| Julie A. Cullivan | HTFL | Common Stock | Sale | -25% | $228,050 | $25.00 | -9,122 | 27,291 | 05 Mar 2026 | Direct |
| Timothy C. Barabe | HTFL | Common Stock | Options Exercise | 1.48% | 2,497 | 170,854 | 17 Feb 2026 | Direct | ||
| Timothy C. Barabe | HTFL | Stock Option | Options Exercise | -100% | -2,497 | 0 | 17 Feb 2026 | Direct | ||
| Campbell Rogers | HTFL | Common Stock | Sale | -46.2% | $1,595,486 | $24.49 | -65,153 | 76,034 | 12 Feb 2026 | Direct |
| Campbell Rogers | HTFL | Common Stock | Options Exercise | 90.4% | 67,016 | 141,187 | 12 Feb 2026 | Direct | ||
| Campbell Rogers | HTFL | Stock Option | Options Exercise | -100% | -67,016 | 0 | 12 Feb 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Sale | -3.67% | $619,553 | $27.46 | -22,562 | 591,656 | 10 Feb 2026 | Direct |
| Marie L. Jones | HTFL | Common Stock. | Award | 215.8% | 21,629 | 31,650 | 06 Feb 2026 | Direct | ||
| Marie L. Jones | HTFL | Common Stock. | Tax liability | -0.93% | -94 | 10,021 | 06 Feb 2026 | Direct | ||
| Marie L. Jones | HTFL | Stock Option | Award | 37,795 | 37,795 | 06 Feb 2026 | Direct | |||
| John C.m. Farquhar | HTFL | Common Stock | Award | 42.7% | 183,850 | 614,218 | 06 Feb 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Tax liability | -0.36% | -1,541 | 430,368 | 06 Feb 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Stock Option | Award | 321,259 | 321,259 | 06 Feb 2026 | Direct | |||
| Campbell Rogers | HTFL | Common Stock | Award | 269% | 54,073 | 74,171 | 06 Feb 2026 | Direct | ||
| Campbell Rogers | HTFL | Common Stock | Tax liability | -2.5% | -515 | 20,098 | 06 Feb 2026 | Direct | ||
| Campbell Rogers | HTFL | Stock Option | Award | 94,488 | 94,488 | 06 Feb 2026 | Direct | |||
| Vikram Verghese | HTFL | Common Stock. | Award | 47.4% | 68,493 | 212,863 | 06 Feb 2026 | Direct | ||
| Vikram Verghese | HTFL | Common Stock. | Tax liability | -0.37% | -542 | 144,370 | 06 Feb 2026 | Direct | ||
| Vikram Verghese | HTFL | Stock Option | Award | 119,685 | 119,685 | 06 Feb 2026 | Direct | |||
| Julie A. Cullivan | HTFL | Common Stock | Sale | -18% | $218,560 | $27.32 | -8,000 | 36,413 | 05 Feb 2026 | Direct |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -16.1% | $56,100,000 | $28.05 | -2,000,000 | 10,448,158 | 04 Feb 2026 | See footnotes |
| Jeffrey C. Lightcap | HTFL | Common Stock | Purchase | $1,053,680 | $26.34 | 40,000 | 40,000 | 16 Dec 2025 | Direct | |
| Campbell Rogers | HTFL | Common Stock | Tax liability | -2.09% | -439 | 20,613 | 07 Nov 2025 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Tax liability | -0.31% | -1,339 | 431,909 | 07 Nov 2025 | Direct | ||
| Vikram Verghese | HTFL | Common Stock. | Tax liability | -0.32% | -471 | 144,912 | 07 Nov 2025 | Direct | ||
| Marie L. Jones | HTFL | Common Stock. | Tax liability | -0.79% | -81 | 10,115 | 07 Nov 2025 | Direct | ||
| HealthCor Partners Management LP | HTFL | Common Stock | Conversion of derivative security | 4,615,542 | 4,615,542 | 11 Aug 2025 | By HCPCIV 1, LLC | |||
| HealthCor Partners Management LP | HTFL | Common Stock | Conversion of derivative security | 833,075 | 833,075 | 11 Aug 2025 | By HealthCor Partners Fund II, L.P. | |||
| HealthCor Partners Management LP | HTFL | Common Stock | Conversion of derivative security | 1,248,939 | 1,248,939 | 11 Aug 2025 | By HealthCor Partners Fund, L.P. | |||
| HealthCor Partners Management LP | HTFL | Convertible Promissory Note | Conversion of derivative security | -100% | -96,068 | 0 | 11 Aug 2025 | By HCPCIV 1, LLC | ||
| HealthCor Partners Management LP | HTFL | Series F-1 Preferred Stock | Conversion of derivative security | -100% | -452,528 | 0 | 11 Aug 2025 | By HCPCIV 1, LLC | ||
| HealthCor Partners Management LP | HTFL | Series F Preferred Stock | Conversion of derivative security | -100% | -1,337,337 | 0 | 11 Aug 2025 | By HCPCIV 1, LLC | ||
| HealthCor Partners Management LP | HTFL | Series E Preferred Stock | Conversion of derivative security | -100% | -1,099,378 | 0 | 11 Aug 2025 | By HCPCIV 1, LLC | ||
| HealthCor Partners Management LP | HTFL | Series D Preferred | Conversion of derivative security | -100% | -208,604 | 0 | 11 Aug 2025 | By HealthCor Partners Fund II, L.P. | ||
| HealthCor Partners Management LP | HTFL | Series D Preferred | Conversion of derivative security | -100% | -1,630,231 | 0 | 11 Aug 2025 | By HCPCIV 1, LLC |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.